Details for New Drug Application (NDA): 217319
✉ Email this page to a colleague
The generic ingredient in SEVELAMER CARBONATE is sevelamer carbonate. There are thirty-two drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the sevelamer carbonate profile page.
Summary for 217319
Tradename: | SEVELAMER CARBONATE |
Applicant: | Chartwell Rx |
Ingredient: | sevelamer carbonate |
Patents: | 0 |
Pharmacology for NDA: 217319
Mechanism of Action | Phosphate Chelating Activity |
Suppliers and Packaging for NDA: 217319
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
SEVELAMER CARBONATE | sevelamer carbonate | FOR SUSPENSION;ORAL | 217319 | ANDA | Hangzhou Anprime Biopharm Co., Ltd. | 72823-301 | 72823-301-05 | 90 PACKAGE in 1 CARTON (72823-301-05) / 1 POWDER, FOR SUSPENSION in 1 PACKAGE (72823-301-01) |
SEVELAMER CARBONATE | sevelamer carbonate | FOR SUSPENSION;ORAL | 217319 | ANDA | Hangzhou Anprime Biopharm Co., Ltd. | 72823-302 | 72823-302-05 | 90 PACKAGE in 1 CARTON (72823-302-05) / 1 POWDER, FOR SUSPENSION in 1 PACKAGE (72823-302-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | FOR SUSPENSION;ORAL | Strength | 800MG/PACKET | ||||
Approval Date: | Mar 2, 2023 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | FOR SUSPENSION;ORAL | Strength | 2.4GM/PACKET | ||||
Approval Date: | Mar 2, 2023 | TE: | AB | RLD: | No |
Complete Access Available with Subscription